🇦🇺Australia
ACCC Labelling Fines
1 verified sources
Definition
Non-compliant ingredient labelling during CPSA triggers ACCC investigations, fines, and mandatory recalls.
Key Findings
- Financial Impact: Fines up to $10 million AUD for corporations; $500,000 AUD for individuals; product recalls.
- Frequency: Per mislabelled batch or ACCC audit.
- Root Cause: Manual transcription errors in INCI lists and failure to verify formulations against labels.
Why This Matters
This pain point represents a significant opportunity for B2B solutions targeting Personal Care Product Manufacturing.
Affected Stakeholders
Labelling Specialist, Quality Assurance, CPSA Assessor
Action Plan
Run AI-powered research on this problem. Each action generates a detailed report with sources.
Methodology & Sources
Data collected via OSINT from regulatory filings, industry audits, and verified case studies.
Related Business Risks
AICIS Non-Compliance Fines
Fines up to $10 million AUD for corporations; product recalls and market withdrawal.
TGA SUSMP Violation Penalties
Heavy fines (e.g., 2023 mercury cream cases); mandatory recalls and product bans.
AICIS Assessment & Reporting Costs
20-40 hours per new product CPSA; annual declaration by Nov 30.
CPSA Product Recall Costs
AUD 50K-500K+ per recall event (logistics, disposal, fines).
Cost of Poor Quality in Batch Production
AUD 20,000-100,000 per year in rework, disposal, and stability testing for SMEs (2-5% of production costs based on industry standards)
Capacity Loss from Quality Rework
AUD 10-40 hours per rework incident (AUD 500-2,000 at AUD 50/hr labor + overhead)